Repositioning Molecules of Chinese Medicine to Targets of SARS-Cov-2 by Deep Learning Method

被引:7
|
作者
Song, Tao [1 ,2 ]
Zhong, Yue [1 ]
Ding, Mao [3 ]
Zhao, Renteng [4 ]
Tian, Qingyu [1 ]
Du, Zhenzhen [1 ]
Liu, Dayan [1 ]
Liu, Jiali [1 ]
Deng, Yufeng [1 ]
机构
[1] China Univ Petr East China, Coll Comp Sci & Technol, Qingdao 266580, Peoples R China
[2] Univ Politecn Madrid, Fac Comp Sci, Dept Artificial Intelligence, Campus Montegancedo, Madrid 28660, Spain
[3] Shandong Univ, Hosp 2, Dept Intens Care Unit, Jinan 250033, Peoples R China
[4] Trinity Earth Technol Co Ltd, Mumbai, Maharashtra, India
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; Chinese medicine; deep convolutional neural network; drug reposition; SYSTEMS;
D O I
10.1109/BIBM49941.2020.9313151
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traditional Chinese medicine has been used to treat and prevent infectious diseases for thousands of years, and has accumulated a large number of effective prescriptions. Deep learning methods provide powerful applications in calculating interactions between drugs and targets. In this study, we try to use the method of deep learning to reposition molecules of Chinese medicines (CMs) and the targets of syndrome coronavirus 2 (SARS-CoV-2). A deep convolution neural network with residual module (DCNN-Res) is constructed and trained on KIBA dataset. The accuracy of predicting the binding affinity of drug-target pairs is 85.33%. By ranking binding affinity scores of 433 molecules in 35 CMs to 6 targets of SARS-Cov-2, DCNN-Res recommends 30 possible repositioning molecules. The consistency between our result and the latest research is 0.827. The molecules in Gancao and Huangqin have a strong binding affinity to targets of SARS-CoV-2, which is also consistent with the latest research.
引用
收藏
页码:2306 / 2312
页数:7
相关论文
共 50 条
  • [1] Peptide Targets to SARS-CoV-2
    Mandal, Santi M.
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (04) : 234 - +
  • [2] Virtual screening of 3.7 billion molecules against SARS-COV-2 targets
    Roy, Amitava
    Venkatraman, Vishwesh
    Colligan, Thomas
    Copeland, Conner
    Gaiser, Jeremiah
    Olson, Daniel
    Wheeler, Travis
    PROTEIN SCIENCE, 2021, 30 : 123 - 123
  • [3] Predicting the antigenic evolution of SARS-COV-2 with deep learning
    Han, Wenkai
    Chen, Ningning
    Xu, Xinzhou
    Sahil, Adil
    Zhou, Juexiao
    Li, Zhongxiao
    Zhong, Huawen
    Gao, Elva
    Zhang, Ruochi
    Wang, Yu
    Sun, Shiwei
    Cheung, Peter Pak-Hang
    Gao, Xin
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [4] Predicting the antigenic evolution of SARS-COV-2 with deep learning
    Wenkai Han
    Ningning Chen
    Xinzhou Xu
    Adil Sahil
    Juexiao Zhou
    Zhongxiao Li
    Huawen Zhong
    Elva Gao
    Ruochi Zhang
    Yu Wang
    Shiwei Sun
    Peter Pak-Hang Cheung
    Xin Gao
    Nature Communications, 14
  • [5] T Lymphocytes as Targets for SARS-CoV-2
    Elena M. Kuklina
    Biochemistry (Moscow), 2022, 87 : 566 - 576
  • [6] Integrins as Therapeutic Targets for SARS-CoV-2
    Gressett, Timothy E.
    Nader, Danielle
    Robles, Juan Pablo
    Buranda, Tione
    Kerrigan, Steven W.
    Bix, Gregory
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [7] T Lymphocytes as Targets for SARS-CoV-2
    Kuklina, Elena M.
    BIOCHEMISTRY-MOSCOW, 2022, 87 (06) : 566 - 576
  • [8] Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
    Wang, Zhonglei
    Yang, Liyan
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 270
  • [9] Selective Electrochemical Detection of SARS-CoV-2 Using Deep Learning
    Gecgel, Ozhan
    Ramanujam, Ashwin
    Botte, Gerardine G.
    VIRUSES-BASEL, 2022, 14 (09):
  • [10] A Deep Learning Approach to Forecast SARS-CoV-2 on the Peruvian Coast
    Luis Aguilar, I
    Ibanez-Reluz, Miguel
    Aguilar, Juan C. Z.
    Zavaleta-Aguilar, Eli W.
    Antonio Aguilar, L.
    COMPUTATIONAL SCIENCE AND ITS APPLICATIONS, ICCSA 2021, PT III, 2021, 12951 : 304 - 319